IRS' IP Pricing In Medtronic Case Untenable, Witness Says

By Joshua Rosenberg · June 21, 2021, 8:08 PM EDT

The pricing method the IRS has argued Medtronic should have employed when licensing intangible property to its Puerto Rican affiliate doesn't withstand scrutiny, a witness for the corporation said Monday, contending...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login